Teva Pharmaceutical Industries Ltd
TASE:TEVA
Teva Pharmaceutical Industries Ltd
Accounts Receivables
Teva Pharmaceutical Industries Ltd
Accounts Receivables Peer Comparison
Competitive Accounts Receivables Analysis
Latest Figures & CAGR of Competitors
Company | Accounts Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Teva Pharmaceutical Industries Ltd
TASE:TEVA
|
Accounts Receivables
$3.5B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-4%
|
|
Taro Pharmaceutical Industries Ltd
NYSE:TARO
|
Accounts Receivables
$177.5m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
2%
|
|
I
|
InterCure Ltd
TASE:INCR
|
Accounts Receivables
₪201.5m
|
CAGR 3-Years
132%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
76%
|
Mediwound Ltd
NASDAQ:MDWD
|
Accounts Receivables
$3.7m
|
CAGR 3-Years
10%
|
CAGR 5-Years
46%
|
CAGR 10-Years
N/A
|
|
R
|
Rekah Pharmaceutical Industry Ltd
TASE:REKA
|
Accounts Receivables
₪124.9m
|
CAGR 3-Years
11%
|
CAGR 5-Years
10%
|
CAGR 10-Years
3%
|
C
|
Cannassure Therapeutics Ltd
TASE:CSURE
|
Accounts Receivables
₪4.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Teva Pharmaceutical Industries Ltd's Accounts Receivables?
Accounts Receivables
3.5B
USD
Based on the financial report for Mar 31, 2024, Teva Pharmaceutical Industries Ltd's Accounts Receivables amounts to 3.5B USD.
What is Teva Pharmaceutical Industries Ltd's Accounts Receivables growth rate?
Accounts Receivables CAGR 10Y
-4%
Over the last year, the Accounts Receivables growth was 1%. The average annual Accounts Receivables growth rates for Teva Pharmaceutical Industries Ltd have been -9% over the past three years , -8% over the past five years , and -4% over the past ten years .